These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24045233)

  • 1. Development of a cysteine-deprived and C-terminally truncated GLP-1 receptor.
    Underwood CR; Knudsen LB; Garibay PW; Peters GH; Reedtz-Runge S
    Peptides; 2013 Nov; 49():100-8. PubMed ID: 24045233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
    Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
    J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
    Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
    J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
    Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
    Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
    Heller RS; Kieffer TJ; Habener JF
    Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of glucagon-like peptide-1 receptor-binding determinants.
    Xiao Q; Jeng W; Wheeler MB
    J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
    Wang H; Hu W; Liu D; Wüthrich K
    FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Dual GLP-1/GIP Receptor Agonist Does Not Antagonize Glucagon at Its Receptor but May Act as a Biased Agonist at the GLP-1 Receptor.
    Al-Zamel N; Al-Sabah S; Luqmani Y; Adi L; Chacko S; Schneider TD; Krasel C
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31330984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional coupling of Cys-226 and Cys-296 in the glucagon-like peptide-1 (GLP-1) receptor indicates a disulfide bond that is close to the activation pocket.
    Mann RJ; Al-Sabah S; de Maturana RL; Sinfield JK; Donnelly D
    Peptides; 2010 Dec; 31(12):2289-93. PubMed ID: 20869417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide binding at the GLP-1 receptor.
    Mann R; Nasr N; Hadden D; Sinfield J; Abidi F; Al-Sabah S; de Maturana RL; Treece-Birch J; Willshaw A; Donnelly D
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):713-6. PubMed ID: 17635131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonist-induced internalisation of the glucagon-like peptide-1 receptor is mediated by the Gαq pathway.
    Thompson A; Kanamarlapudi V
    Biochem Pharmacol; 2015 Jan; 93(1):72-84. PubMed ID: 25449603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular cloning and characterization of a parathyroid hormone/parathyroid hormone-related peptide receptor: a member of an ancient family of G protein-coupled receptors.
    Jüppner H
    Curr Opin Nephrol Hypertens; 1994 Jul; 3(4):371-8. PubMed ID: 8076140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structure-function studies of a glucagon-like peptide 1 receptor from goldfish Carassius auratus: identification of three charged residues in extracellular domains critical for receptor function.
    Yeung CM; Mojsov S; Mok PY; Chow BK
    Endocrinology; 2002 Dec; 143(12):4646-54. PubMed ID: 12446592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain.
    Runge S; Thøgersen H; Madsen K; Lau J; Rudolph R
    J Biol Chem; 2008 Apr; 283(17):11340-7. PubMed ID: 18287102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
    Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
    Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human glucagon-like peptide-1 receptor polymorphism results in reduced agonist responsiveness.
    Beinborn M; Worrall CI; McBride EW; Kopin AS
    Regul Pept; 2005 Aug; 130(1-2):1-6. PubMed ID: 15975668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lateral allosterism in the glucagon receptor family: glucagon-like peptide 1 induces G-protein-coupled receptor heteromer formation.
    Schelshorn D; Joly F; Mutel S; Hampe C; Breton B; Mutel V; Lütjens R
    Mol Pharmacol; 2012 Mar; 81(3):309-18. PubMed ID: 22108912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
    Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
    PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
    Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
    Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity.
    Vázquez P; Roncero I; Blázquez E; Alvarez E
    J Endocrinol; 2005 Apr; 185(1):35-44. PubMed ID: 15817825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.